A study on liposomal encapsulation of a lipophilic prodrug of LHRH

Pharm Dev Technol. 2016 Sep;21(6):664-71. doi: 10.3109/10837450.2015.1041045. Epub 2015 May 6.

Abstract

This study aimed at evaluating whether derivatization of luteinizing hormone-releasing hormone (LHRH) peptide with an amphiphilic lipoamino acid moiety could allow, along with other technological and/or pharmacokinetic advantages, to improve its encapsulation in liposomes, potentially driving its further body distribution and cellular uptake. Experimental data confirmed that a lipophilic derivative of LHRH was efficiently incorporated in various liposomal systems, differing in lipid composition and surface charge, and obtained using different methods of production. Incubation of liposomes, loaded with a fluorescent derivative of the LHRH prodrug, with NCTC keratinocytes or Caco-2 cell cultures showed that the carriers can be rapidly internalized. Conversely, the internalization of the free prodrug occurred only at very high concentrations.

Keywords: Amphiphilicity; LUVET liposomes; MLV liposomes; REV liposomes; cell uptake; fluorescence microscopy; lipoamino acids.

MeSH terms

  • Caco-2 Cells
  • Cell Survival / drug effects
  • Cell Survival / physiology
  • Dose-Response Relationship, Drug
  • Drug Compounding
  • Gonadotropin-Releasing Hormone / administration & dosage*
  • Gonadotropin-Releasing Hormone / metabolism*
  • Humans
  • Keratinocytes / drug effects
  • Keratinocytes / metabolism
  • Liposomes
  • Prodrugs / administration & dosage*
  • Prodrugs / metabolism*

Substances

  • Liposomes
  • Prodrugs
  • Gonadotropin-Releasing Hormone